Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
[MEDICAL CANNABIS].
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
Optic neuritis and TNF antagonists in IBD.
Get glammed up.
HLA Genetic Risk Burden in Multiple Sclerosis-Reply.
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.
A Microsoft Kinect-Based Point-of-Care Gait Assessment Framework for Multiple Sclerosis Patients.
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
Walk them or no leg to stand on! Diagnostic delay of neurologic conditions in young children.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Neurologic indications for therapeutic plasma exchange: 2011 update.
Detection of Thyroid Abnormalities in Aquaporin-4 Antibody-Seropositive Optic Neuritis Patients.
Differential Effects of Stress on Microglial Cell Activation in Male and Female Medial Prefrontal Cortex.
Genetics of rat neuroinflammation.
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome.
Environmental factors in autoimmune diseases and their role in multiple sclerosis.
Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities.
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Temporal Course of Neurodegenerative Effects on Cognition in Old Age .
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Pages
« first
‹ previous
…
740
741
742
743
744
745
746
747
748
…
next ›
last »